Vimal Drugs Private Limited, a active private limited company, was established on 05 May 2009 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2009PTC063551. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹3.99 Cr.
It upholds a compliant status. Employing 139 professional, Its leadership includes Venkata Ravi Kumar Vasireddy (Director), Vasireddy Renuka Devi (Director), Satish Mallela (Additional Director). Past directors included Mullangi Suresh, Inti Kasi Viswanadh, Jagadam Satyanarayana. It holds ₹34.14 Cr open charges and ₹54.37 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at # 4B & 5B, Sri Teja Residency, Ravendra Society Kakatiya Hills, Kavuri Hills, Madhapur, Hyderabad, Telangana, 500081.
U24100TG2009PTC063551
063551
05 May 2009
₹7.00 Cr
₹3.99 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Vimal Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Ravi Kumar Vasireddy | Director | 21 Nov 2015 | Current |
| Vasireddy Renuka Devi | Director | 17 Jan 2020 | Current |
| Satish Mallela | Additional Director | 13 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Oct 2015 | Past |
| Pramod Abcsdd | Director | 06 Oct 2015 | Past |
| Pramod Abcsdd | Director | 06 Oct 2015 | Past |
| Pramod Abcsdd | Managing Director | 20 Sep 2014 | Past |
| Pramod Abcsdd | Director | 28 May 2012 | Past |
| Pramod Abcsdd | Director | 15 Jun 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vimal Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.57% decrease. The company also saw a substantial fall in profitability, with a 92.57% decrease in profit. The company's net worth moved up by a moderate rise of 5.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Vimal Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹341,435,423.00
₹543,654,580.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2025 | Others | ₹7.83 M | Open |
| 29 Sep 2024 | Others | ₹33.00 Cr | Open |
| 06 Jul 2024 | Hdfc Bank Limited | ₹3.01 M | Open |
| 03 Jan 2024 | Hdfc Bank Limited | ₹0.60 M | Open |
| 02 May 2025 | Others | ₹3.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Vimal Drugs has a workforce of 139 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vimal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vimal Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 02 May 2025 via Charge ID 101097770 with Others was fully satisfied on 05 Aug 2025. was documented.
A charge registered on 07 Feb 2024 via Charge ID 100863324 with Others was fully satisfied on 22 May 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 3.50 Cr with Charge ID 101097770 was registered on 02 May 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 0.78 Cr with Charge ID 101081076 was registered on 28 Feb 2025. was recorded as a recent event.
The activity Vimal Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Others amounted to Rs. 33.00 Cr with Charge ID 100981964 was registered on 29 Sep 2024. was recorded as a recent event.
The CIN of Vimal Drugs Private Limited is U24100TG2009PTC063551.
Vimal Drugs Private Limited is headquartered at # 4B & 5B, Sri Teja Residency, Ravendra Society Kakatiya Hills, Kavuri Hills, Madhapur, Hyderabad, Telangana, 500081.
Vimal Drugs Private Limited was incorporated on 05 May 2009.
The current directors of Vimal Drugs Private Limited are
The primary industry of Vimal Drugs Private Limited is Manufacturing.
Vimal Drugs Private Limited is unlisted.
The authorized capital of Vimal Drugs Private Limited is ₹7.00 Cr, and the paid-up capital is ₹3.99 Cr.
The compliance status of Vimal Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX